Latest Strategic Partnerships News

Jade Gas has appointed Richy Xie as a strategic advisor to deepen its Asia-Pacific engagement while securing A$12 million in a premium-priced placement to accelerate its Mongolian gas project development.

Pure Resources has appointed retired Vice Admiral Jeff Trussler to its advisory board, leveraging his deep US Navy and national security networks to accelerate US government funding and integration of its advanced materials into defence supply chains.

Tetratherix Limited (ASX:TTX) has launched a $2 million share purchase plan offering eligible Australian and New Zealand shareholders the chance to buy shares at a 2% discount to recent trading prices. The non-underwritten SPP opens on 4 June and closes on 18 June 2026.

IperionX’s Definitive Feasibility Study for its Titan Project in Tennessee reveals a robust 14-year mine plan producing critical heavy rare earths, titanium minerals, and zircon with strong financial returns and US government backing.

Magnum Mining has completed OTCIQ submissions to secure a U.S. OTCID listing, enhancing access for American investors as it accelerates exploration across its Brazilian and U.S. rare earth, gold, and copper projects.

Tivan Limited has locked in a minimum $15 million funding package through a $10 million option underwriting agreement and a $5 million share placement with strategic investor ETFS Capital, supporting accelerated development across its Australian and Timor-Leste projects.

ImpediMed has revamped its leadership with two new commercial roles and reported encouraging sales momentum for its SOZO device. The company is advancing clinical trials and expanding its presence in cancer survivorship, weight management, and heart health sectors.

Vitrafy Life Sciences has teamed up with Vitalant Innovation Center to tackle the impending gap in red blood cell cryopreservation technology in the US, aiming to replace soon-to-be-discontinued legacy methods and potentially expand into other blood products.

Imagion Biosystems has secured FDA clearance to proceed with its Phase 1b/2 trial of the MagSense® HER2 Imaging Agent, targeting improved detection of HER2+ breast cancer. Patient recruitment is expected to start in Q3 2026, marking a crucial step toward commercialisation.

Viridis Mining has secured a non-binding Letter of Intent with Solvay to supply Mixed Rare Earth Carbonate from its Colossus Project, aiming for commercial production by 2028 and advancing Western-aligned rare earth supply chains.

Aura Energy has secured a strategic non-binding MOU with a major international nuclear utility, underpinning funding and technical collaboration for its Tiris Uranium Project in Mauritania. The company has locked in a robust processing flowsheet and aims for a Final Investment Decision by the end of 2026.

ReNerve has inked an exclusive three-year deal with Hong Kong’s Swedish Trading Company to distribute its nerve repair products across a vast and dynamic healthcare region.